Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

Kim, Stephanie I; Szeto, Andy H; Morgan, Katherine P; Brower, Blaine; Dunn, Mary W; Khandani, Amir H; Godley, Paul A; Rose, Tracy L et al. · PLoS One · 2021

Where this comes from

Record sourced from PubMed, PMID 34972194.
Also identified by DOI 10.1371/journal.pone.0262326 and PMC identifier 8719726.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0253021.].

Read the full text

View on PubMed · Publisher (DOI)